Tetsuaki Hirase

ORCID: 0000-0003-1691-8003
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Atherosclerosis and Cardiovascular Diseases
  • Barrier Structure and Function Studies
  • Nitric Oxide and Endothelin Effects
  • Metabolism, Diabetes, and Cancer
  • Diabetes Treatment and Management
  • Diabetes Management and Research
  • Pancreatic function and diabetes
  • Protease and Inhibitor Mechanisms
  • Renin-Angiotensin System Studies
  • Adipose Tissue and Metabolism
  • Biomarkers in Disease Mechanisms
  • Cancer, Lipids, and Metabolism
  • Computational Drug Discovery Methods
  • Lipoproteins and Cardiovascular Health
  • Cancer-related molecular mechanisms research
  • Diabetes and associated disorders
  • Angiogenesis and VEGF in Cancer
  • Coronary Interventions and Diagnostics
  • Cardiovascular Disease and Adiposity
  • Eicosanoids and Hypertension Pharmacology
  • Cell Adhesion Molecules Research
  • Diet and metabolism studies
  • Cancer, Hypoxia, and Metabolism
  • Chemokine receptors and signaling
  • Neurological Disease Mechanisms and Treatments

Eli Lilly (Japan)
2018-2025

National Cerebral and Cardiovascular Center
2010-2017

Saga University
2004-2013

Kobe University
1996-2004

Providence VA Medical Center
2003

Saga Medical School Hospital
2003

Japan Synchrotron Radiation Research Institute
2002

Kumamoto University
2002

Osaka University
2002

Ministry of Education, Culture, Sports, Science and Technology
2001-2002

Recently, we found that ZO-1, a tight junction-associated protein, was concentrated in the so called isolated adherens junction fraction from liver (Itoh, M., A. Nagafuchi, S. Yonemura, T. Kitani-Yasuda, Sa. Tsukita, and Sh. Tsukita. 1993. J. Cell Biol. 121:491-502). Using this derived chick as an antigen, obtained three monoclonal antibodies specific for approximately 65-kD protein rats. This antigen not extractable plasma membranes without detergent, suggesting it is integral membrane...

10.1083/jcb.123.6.1777 article EN The Journal of Cell Biology 1993-12-15

Occludin is an integral membrane protein localizing at tight junctions (TJ) with four transmembrane domains and a long COOH-terminal cytoplasmic domain (domain E) consisting of 255 amino acids. Immunofluorescence laser scan microscopy revealed that chick full-length occludin introduced into human bovine epithelial cells was correctly delivered to incorporated preexisting TJ. Further transfection studies various deletion mutants showed the E, especially its approximately 150 acids E358/504),...

10.1083/jcb.127.6.1617 article EN The Journal of Cell Biology 1994-12-15

ABSTRACT Endothelial cells provide a crucial interface between blood and tissue environments. Free diffusion of substances across endothelia is prevented by the endothelial tight junction, permeability which varies enormously depending on tissue. blood-brain barrier possess junctions severely limited permeability, whereas those non-neural are considerably leakier, but molecular basis for this difference not clear. Occludin major transmembrane protein localizing at junction. In study, we...

10.1242/jcs.110.14.1603 article EN Journal of Cell Science 1997-07-15

Occludin has been identified from chick liver as a novel integral membrane protein localizing at tight junctions (Furuse, M., T. Hirase, M. Itoh, A. Nagafuchi, S. Yonemura, Sa. Tsukita, and Sh. Tsukita. 1993. J. Cell Biol. 123:1777-1788). To analyze modulate the functions of junctions, it would be advantageous to know mammalian homologues occludin their genes. Here we describe nucleotide sequences full length cDNAs encoding rat-kangaroo (potoroo), human, mouse, dog. Rat-kangaroo cDNA was...

10.1083/jcb.133.1.43 article EN The Journal of Cell Biology 1996-04-01

Nitric oxide (NO) derived from endothelial NO synthase (eNOS) is regarded as a protective factor against atherosclerosis. Therefore, augmentation of eNOS expression or production by pharmacological intervention postulated to inhibit We crossed eNOS-overexpressing (eNOS-Tg) mice with atherogenic apoE-deficient (apoE-KO) determine whether overexpression in the endothelium could development After 8 weeks on high-cholesterol diet, atherosclerotic lesion areas aortic sinus were unexpectedly...

10.1172/jci15215 article EN Journal of Clinical Investigation 2002-08-01

In epithelial and endothelial cells, tight junctions regulate the paracellular permeability of ions proteins. Disruption by inflammation is often associated with tissue edema, but regulatory mechanisms are not fully understood. Using ECV304 cells as a model system, lysophosphatidic acid histamine were found to increase tracer horseradish peroxidase. Cytoskeletal changes induced these agents included stimulation stress fiber formation myosin light chain phosphorylation. Additionally,...

10.1074/jbc.m007136200 article EN cc-by Journal of Biological Chemistry 2001-03-01

Nitric oxide (NO) derived from endothelial NO synthase (eNOS) is regarded as a protective factor against atherosclerosis. Therefore, augmentation of eNOS expression or production by pharmacological intervention postulated to inhibit We crossed eNOS-overexpressing (eNOS-Tg) mice with atherogenic apoE-deficient (apoE-KO) determine whether overexpression in the endothelium could development After 8 weeks on high-cholesterol diet, atherosclerotic lesion areas aortic sinus were unexpectedly...

10.1172/jci0215215 article EN Journal of Clinical Investigation 2002-08-01

ABSTRACT Occludin is an integral membrane protein localizing at tight junctions with four transmembrane domains. When chicken occludin was overexpressed in insect cells by recombinant baculovirus infection, peculiar multilamellar structures accumulated the cytoplasm. Partial isolation of these indicated that introduced highly enriched structures. Thin section electron microscopy revealed each lamella transformed from intracellular membranous cisternae whose luminal space completely...

10.1242/jcs.109.2.429 article EN Journal of Cell Science 1996-02-01

Monocyte/macrophage infiltration to the arterial wall is an initial step in atherosclerosis, and monocyte chemoattractant protein-1 (MCP-1) thought play a central role recruitment of these cells. In present study, we examined local expression MCP-1 at vessel initiation development atherosclerosis. We transfected cDNA encoding rat into rabbit carotid artery with use hemagglutinating virus Japan (HVJ)-liposome method. The rabbits were divided following groups: (1) those fed normal chow...

10.1161/hq0102.102278 article EN Arteriosclerosis Thrombosis and Vascular Biology 2002-01-01

Empagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, ameliorates hyperglycemia in patients with type diabetes (T2D) by inducing sustained glucosuria. Empagliflozin treatment was previously associated transient increase 24-h urine volume Caucasian T2D, however comparable evidence Japanese T2D individuals is scarce. We therefore assessed acute and chronic changes fluid intake empagliflozin T2D.In this randomized, double-blind, placebo-controlled, parallel-group, multiple-dose,...

10.1007/s13300-018-0385-5 article EN cc-by-nc Diabetes Therapy 2018-02-27

Background and Purpose— Recent clinical studies suggest that 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) exert protective effects against nonhemorrhagic stroke. In a murine cerebral ischemia model produced by occlusion of the middle artery, statins were shown to reduce infarct size. However, effect on hypertension-based stroke is unknown. The purpose this study clarify statin in stroke-prone spontaneously hypertensive rats (SHR-SP), which both hemorrhage...

10.1161/01.str.0000048213.18751.52 article EN Stroke 2003-01-01

Chronic inflammation in arterial wall that is driven by immune cells and cytokines plays pivotal roles the development of atherosclerosis. Interleukin 27 (IL-27) a member IL-12 family consists IL-27p28 Epstein-Barr virus induced gene 3 (EBI3) has anti-inflammatory properties regulate T cell polarization cytokine production. IL-27-deficient ( Ldlr−/− Ebi3−/−) IL-27 receptor-deficient WSX-1−/−) mice were generated fed with high-cholesterol diet to induce Roles bone marrow-derived vivo...

10.1152/ajpheart.00198.2013 article EN AJP Heart and Circulatory Physiology 2013-06-01

Pentraxin-3 (PTX3) reportedly has protective roles in atherosclerosis and myocardial infarction, is a useful biomarker of vascular inflammation. However, the detailed functions PTX3 inflammation are yet to be elucidated. This study aimed investigate function macrophages.PMA-treated THP-1 cell line (THP-1 macrophage) monocyte-derived human primary macrophages were treated with recombinant PTX3. Cytokine chemokine levels culture medium measured as well monocyte chemoattractant protein (MCP-1)...

10.1016/j.bbrep.2016.01.009 article EN cc-by Biochemistry and Biophysics Reports 2016-01-14

Obesity prevalence has increased in Japan recent years. Given the strong association of obesity with poor glycemic control, and risk type 2 diabetes (T2D) central obesity, this study describes current trends relationships between glycated hemoglobin (HbA1c), body mass index (BMI), waist circumference Japanese people T2D. This was a retrospective, cross-sectional T2D who had at least one recorded HbA1c BMI (or circumference) value Medical Data Center Claims database. Five annual cohorts...

10.1007/s13300-024-01543-4 article EN cc-by-nc Diabetes Therapy 2024-02-24

Endogenous nitric oxide (NO) inhibits the contractile response to beta-adrenergic stimulation, but its effect on cardiac hypertrophy mediated by beta-adrenoceptors remains unclear. The present study was designed determine whether overproduction of endothelial NO synthase (eNOS) could inhibit induced chronic isoproterenol (ISO) infusion (30mg/kg per day) using eNOS overexpressing (eNOS-Tg) mice and wild-type (WT) mice. In a separate group, WT were treated with ISO hydralazine decrease blood...

10.1253/circj.66.851 article EN Circulation Journal 2002-01-01

Abstract Aim To assess the safety and efficacy of tirzepatide in people East Asian descent based on age body mass index (BMI). Materials Methods Data participants enrolled countries SURPASS‐1, ‐3, ‐4, ‐5, J‐mono J‐combo phase 3 clinical trials were included. Participants with type 2 diabetes a baseline HbA1c 7.0% up to 11.0% BMI 23 kg/m or greater 25 treated 5, 10 15 mg evaluated (94% from Japan) (< 65 ≥ years) ). Key outcomes assessed. Results At baseline, 73% had 74% younger than years....

10.1111/dom.14952 article EN cc-by-nc-nd Diabetes Obesity and Metabolism 2022-12-22

The objective of this work was to assess the association tirzepatide with changes in insulin sensitivity and beta-cell function Japanese patients type 2 diabetes (T2D). This a prespecified analysis SURPASS J-mono, multicenter, randomized, double-blind, active-controlled phase 3 study participants T2D. Participants were randomly assigned receive 5, 10, 15 mg, or dulaglutide 0.75 mg once weekly for 52 weeks. Changes from baseline homeostatic model assessment (HOMA2) parameters assessed by...

10.1007/s13300-025-01704-z article EN cc-by-nc Diabetes Therapy 2025-02-14

BackgroundSeveral studies have reported the cost-effectiveness of sodium-glucose co-transporter 2 inhibitors in heart failure patients; however, their economic implications not been sufficiently elucidated Japan.MethodsA Markov cohort model was developed to evaluate empagliflozin plus standard care (SoC) vs. SoC for patients with reduced ejection fraction (HFrEF) Japan. Model inputs, including risk clinical events, costs, and utilities based on Kansas City Cardiomyopathy Questionnaire...

10.1016/j.jjcc.2023.02.007 article EN cc-by-nc-nd Journal of Cardiology 2023-02-28

Objective: Vascular endothelial growth factor (VEGF) is a potent angiogenic and plays an important pathophysiological role in the maintenance of tissue structure as well regeneration after ischemic injury. Three-hydroxy-3methylglutaryl-CoA reductase inhibitors reduce vascular inflammation induce angiogenesis. This study examined whether simvastatin stimulates VEGF expression cells nature its underlying mechanism. Methods Results: Simvastatin induced mRNA protein secretion that were reversed...

10.1097/fjc.0b013e3181624b44 article EN Journal of Cardiovascular Pharmacology 2008-03-01
Coming Soon ...